Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
VMD

VMD - Viemed Healthcare Inc Stock Price, Fair Value and News

6.83USD-0.26 (-3.67%)Market Closed

Market Summary

VMD
USD6.83-0.26
Market Closed
-3.67%

VMD Stock Price

View Fullscreen

VMD RSI Chart

VMD Valuation

Market Cap

265.1M

Price/Earnings (Trailing)

25.67

Price/Sales (Trailing)

1.37

EV/EBITDA

15.43

Price/Free Cashflow

31.29

VMD Price/Sales (Trailing)

VMD Profitability

EBT Margin

7.47%

Return on Equity

8.88%

Return on Assets

6.67%

Free Cashflow Yield

3.2%

VMD Fundamentals

VMD Revenue

Revenue (TTM)

194.0M

Rev. Growth (Yr)

27.9%

Rev. Growth (Qtr)

-0.29%

VMD Earnings

Earnings (TTM)

10.3M

Earnings Growth (Yr)

5.67%

Earnings Growth (Qtr)

-53.9%

Breaking Down VMD Revenue

Last 7 days

2.1%

Last 30 days

3.3%

Last 90 days

-13.3%

Trailing 12 Months

-24.2%

How does VMD drawdown profile look like?

VMD Financial Health

Current Ratio

1.28

Debt/Equity

0.05

Debt/Cashflow

6.08

VMD Investor Care

Shares Dilution (1Y)

1.42%

Diluted EPS (TTM)

0.25

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2024194.0M000
2023146.1M156.1M169.8M183.0M
2022120.9M126.8M133.3M138.8M
2021135.9M120.5M116.3M117.1M
202085.9M108.5M121.6M131.3M
201968.6M73.7M77.2M80.3M
201800064.5M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Viemed Healthcare Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 14, 2024
heltz sabrina
bought
39,954
7.08415
5,640
-
May 09, 2024
zehnder william todd
acquired
-
-
3,251
chief operating officer
May 09, 2024
zehnder william todd
back to issuer
-23,179
7.13
-3,251
chief operating officer
May 09, 2024
hoyt casey
acquired
-
-
4,835
chief executive officer
May 09, 2024
cambre jerome
acquired
-
-
1,028
vice president of sales
May 09, 2024
hoyt casey
back to issuer
-34,473
7.13
-4,835
chief executive officer

1–10 of 50

Which funds bought or sold VMD recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 19, 2024
NISA INVESTMENT ADVISORS, LLC
reduced
-79.55
-712
118
-%
Jul 18, 2024
RAELIPSKIE PARTNERSHIP
sold off
-100
-943
-
-%
Jul 18, 2024
Cove Street Capital, LLC
reduced
-63.87
-6,313,510
2,115,000
1.52%
Jul 16, 2024
Ulland Investment Advisors, LLC
added
48.06
6,000
218,000
0.15%
Jul 11, 2024
SALEM INVESTMENT COUNSELORS INC
unchanged
-
-207,381
471,646
0.01%
Jul 11, 2024
Pacifica Partners Inc.
unchanged
-
-931
2,467
-%
Jul 10, 2024
CWM, LLC
added
7,600
2,000
2,000
-%
Jul 09, 2024
LAZARD ASSET MANAGEMENT LLC
reduced
-36.95
-34,000
106,000
-%
Jul 01, 2024
Legal & General Group Plc
added
39.32
26,784
65,821
-%
May 28, 2024
Boston Partners
unchanged
-
49,730
296,810
-%

1–10 of 49

Are Funds Buying or Selling VMD?

Are funds buying VMD calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own VMD
No. of Funds

Unveiling Viemed Healthcare Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 15, 2024
hoyt casey
8.0%
3,116,189
SC 13G/A
Feb 15, 2024
moore michael
6.5%
2,520,918
SC 13D/A
Feb 14, 2024
nantahala capital management, llc
5.1%
1,952,368
SC 13G
Feb 13, 2024
thrivent financial for lutherans
8.7%
3,347,784
SC 13G/A
Feb 02, 2024
blackrock inc.
5.6%
2,129,167
SC 13G
May 18, 2023
moore michael
6.3%
2,421,319
SC 13D/A
Feb 21, 2023
viemed healthcare, inc.
7.6%
2,973,243
SC 13G/A
Feb 08, 2023
thrivent financial for lutherans
10.88%
4,134,751
SC 13G/A
Oct 18, 2022
thrivent financial for lutherans
10.1%
3,855,125
SC 13G/A
Jul 08, 2022
blackrock inc.
2.4%
967,193
SC 13G

Recent SEC filings of Viemed Healthcare Inc

View All Filings
Date Filed Form Type Document
Jun 06, 2024
8-K
Current Report
May 29, 2024
8-K
Current Report
May 14, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 10, 2024
4
Insider Trading
May 09, 2024
8-K
Current Report
May 06, 2024
8-K
Current Report

Peers (Alternatives to Viemed Healthcare Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
177.6B
40.3B
-1.87% -8.75%
31.54
4.4
-2.84% -3.00%
66.7B
19.7B
-1.27% -12.39%
50.03
3.38
4.82% -17.56%
18.9B
3.9B
3.77% -24.06%
40.93
4.83
5.72% 46.72%
18.0B
14.9B
4.77% -28.30%
6.8
1.21
2.98% 207.68%
MID-CAP
9.7B
3.5B
-0.49% 22.32%
30.92
2.73
6.16% 35.06%
9.0B
12.4B
3.05% -11.95%
23.22
0.73
-0.93% -18.83%
8.5B
2.6B
2.70% -25.47%
-26.25
3.25
-6.25% -68.58%
5.5B
3.9B
2.69% -35.08%
-57.29
1.39
0.23% 90.80%
3.5B
387.1M
0.41% 33.97%
-217.07
8.93
30.82% 65.57%
2.2B
6.6B
-1.26% -22.56%
11.83
0.33
1.50% -10.09%
SMALL-CAP
1.4B
3.2B
-5.25% -24.25%
-2.04
0.44
7.94% -1695.32%
408.8M
169.3M
6.32% 8.33%
-5.32
2.42
7.49% -244.90%
287.6M
324.0M
27.08% -17.85%
-1.5
0.89
-3.19% -337.41%
46.8M
50.5M
-0.74% -76.96%
-2.05
0.93
14.25% -10.06%
5.7M
3.5M
-39.71% -89.21%
-0.47
1.62
-0.62% -1.48%

Viemed Healthcare Inc News

Latest updates
Simply Wall St2 months ago
Cantech Letter14 months ago

Viemed Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-0.3%50,59350,73949,40243,31139,55637,50835,75933,31032,25531,96229,28527,39928,41631,20233,44742,85423,80621,44820,36820,32518,115
Gross Profit-7.2%29,80232,11130,56226,10624,00422,89621,65120,39019,74319,66218,38117,62517,74219,17819,45325,92715,55314,24314,05014,63913,074
  S&GA Expenses3.8%24,81423,90523,65420,56319,76217,17217,67717,53615,77614,24013,26012,88414,50912,27413,55016,42810,57710,17410,23111,5169,460
  R&D Expenses15.2%750651593758780722670672632612576583339395243271174203208203234
EBITDA Margin-3.1%0.09*0.09*0.11*0.09*0.08*0.07*0.19*0.20*0.21*0.21*0.21*0.20*---------
Interest Expenses-36.7%22435432812742.0046.0057.0062.0066.0073.0080.0081.0011712212814416524239.0026.0026.00
Income Taxes-69.2%5001,6241,3207285011,1464564217459681,3861,246-2231511,141-6,64618758.0051.0024.00138
Earnings Before Taxes-58.2%2,1215,0764,2393,0582,0183,5841,5111,3882,5075,0553,1752,8121,4615,2223,94512,7664,4302,4462,9041,3502,096
EBT Margin-5.0%0.07*0.08*0.08*0.07*0.06*0.06*0.08*0.10*0.11*0.11*0.11*0.11*---------
Net Income-53.9%1,6033,4772,9192,3301,5172,4381,0559671,7624,0871,7891,5661,6845,0712,80419,4124,2432,3882,8531,3261,958
Net Income Margin-4.9%0.05*0.06*0.05*0.05*0.04*0.04*0.06*0.07*0.08*0.08*0.09*0.09*---------
Free Cashflow-190.3%-4,8315,3526,4071,5455,8152,1121,635-2,0803,1831,992-3,005933---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets0.0%15515514914912511711911611911811511111311311411287.0083.0080.0071.0059.00
  Current Assets0.7%39.0038.0036.0036.0047.0040.0043.0042.0048.0047.0047.0047.0048.0047.0050.0049.0030.0028.0028.0025.0024.00
    Cash Equivalents-43.1%7.0013.0010.0010.0024.0017.0021.0022.0029.0028.0027.0031.0031.0031.0032.0030.008.0013.0013.008.007.00
  Inventory-6.0%4.005.005.004.003.004.003.003.003.002.003.003.002.002.003.007.002.001.001.004.004.00
  Net PPE-0.1%74.0074.0073.0073.0068.0068.00--64.0063.0059.0054.0054.0055.0056.0055.0057.0055.0052.0046.0035.00
  Goodwill0%30.0030.0030.0030.00-----------------
Liabilities-5.8%39.0041.0041.0045.0025.0020.0026.0023.0023.0023.0026.0025.0030.0031.0039.0041.0038.0039.0040.0035.0025.00
  Current Liabilities-6.2%30.0032.0032.0032.0023.0019.0021.0018.0018.0018.0020.0018.0022.0023.0030.0032.0026.0026.0027.0027.0022.00
  Long Term Debt-1.6%6.006.008.0012.00--4.004.004.004.004.005.005.006.006.007.007.008.008.005.00-
    LT Debt, Current-44.4%1.001.002.003.00--0.001.001.001.002.002.002.002.002.002.002.002.002.000.00-
    LT Debt, Non Current-1.6%6.006.008.0012.00--4.004.004.004.004.005.005.006.006.007.007.008.008.005.00-
Shareholder's Equity2.1%11611410910510097.0094.0093.0096.0095.0089.0086.0083.0082.0075.0071.0049.0044.0040.0036.0034.00
  Retained Earnings0.8%80.0079.0076.0073.0071.0070.0068.0069.0073.0073.0069.0067.0066.0066.0061.0058.0038.0034.0032.0029.0028.00
  Additional Paid-In Capital-8.9%14.0016.0014.0013.0012.0012.0011.0010.009.008.007.005.004.007.006.005.004.006.005.005.004.00
Shares Outstanding0.8%39.0039.0038.0038.0038.0038.0039.0039.0040.0039.0040.0039.00---------
Float----330---182---251---335---117,224-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-91.2%1,17513,28413,8097,62310,4967,6847,9724,9467,1468,6555,0284,1834,6285,7917,33121,3816077,4005,7245,313650
  Share Based Compensation-6.6%1,4321,5341,4531,4711,3911,3171,3091,2711,3051,3051,3021,2361,3071,3011,2341,1961,1519081,0641,034880
Cashflow From Investing28.4%-5,365-7,493-8,508-32,207-3,905-7,378-6,103-6,688-3,807-6,563-8,425-3,060-1,698-5,368-2,4271,091-1,711-2,579-2,745-7,395-92.00
Cashflow From Financing55.8%-1,340-3,030-5,44711,26439.00-4,870-2,313-5,584-2,499-551-887-1,069-2,814-1,838-2,215-1,174-3,842-4,0961,9602,363-3,561
  Buy Backs-1,000----7101,8575,1141,887---1,4341,434-------1,522
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

VMD Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Income Statement [Abstract]  
Revenue$ 50,593$ 39,556
Cost of revenue20,79115,552
Gross profit29,80224,004
Operating expenses  
Selling, general and administrative24,81419,762
Research and development750780
Stock-based compensation1,4321,391
Depreciation and amortization415240
Loss (gain) on disposal of property and equipment213(22)
Other income, net(26)(81)
Income from operations2,2041,934
Non-operating income and expenses  
Income from equity method investments(67)(35)
Interest expense (income), net150(49)
Net income before taxes2,1212,018
Provision for income taxes518501
Net income1,6031,517
Other comprehensive income00
Comprehensive income$ 1,603$ 1,517
Net income per share  
Basic (in dollars per share)$ 0.04$ 0.04
Diluted (in dollars per share)$ 0.04$ 0.04
Weighted average number of common shares outstanding:  
Basic (in shares)38,717,12338,156,777
Diluted (in shares)40,580,63440,016,693

VMD Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
Current assets  
Cash and cash equivalents$ 7,309$ 12,839
Accounts receivable, net24,47718,451
Inventory4,3494,628
Prepaid expenses and other assets2,4832,449
Total current assets38,61838,367
Long-term assets  
Property and equipment, net73,51173,579
Finance lease right-of-use assets297401
Operating lease right-of-use assets2,7332,872
Equity investments1,6981,680
Debt investment2,2742,219
Deferred tax asset4,5584,558
Identifiable intangibles, net534567
Goodwill29,76529,765
Other long-term assets887887
Total long-term assets116,257116,528
TOTAL ASSETS154,875154,895
Current liabilities  
Trade payables5,8004,180
Deferred revenue6,0926,207
Income taxes payable2,6752,153
Accrued liabilities14,05717,578
Finance lease liabilities, current portion199256
Operating lease liabilities, current portion698678
Current portion of long-term debt5961,072
Total current liabilities30,11732,124
Long-term liabilities  
Accrued liabilities447558
Finance lease liabilities, less current portion95132
Operating lease liabilities, less current portion2,0372,184
Long-term debt5,9066,002
Total long-term liabilities8,4858,876
TOTAL LIABILITIES38,60241,000
Commitments and Contingencies00
SHAREHOLDERS' EQUITY  
Common stock - No par value: unlimited authorized; 38,816,766 and 38,506,161 issued and outstanding as of March 31, 2024 and December 31, 2023, respectively21,84218,702
Additional paid-in capital14,29415,698
Retained earnings80,13779,495
TOTAL SHAREHOLDERS' EQUITY116,273113,895
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY$ 154,875$ 154,895
VMD
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
 CEO
 WEBSITEviemed.com
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES974

Viemed Healthcare Inc Frequently Asked Questions


What is the ticker symbol for Viemed Healthcare Inc? What does VMD stand for in stocks?

VMD is the stock ticker symbol of Viemed Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Viemed Healthcare Inc (VMD)?

As of Fri Jul 19 2024, market cap of Viemed Healthcare Inc is 265.15 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers. The fair value of Viemed Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Viemed Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for VMD so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Viemed Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether VMD is over valued or under valued. Whether Viemed Healthcare Inc is cheap or expensive depends on the assumptions which impact Viemed Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VMD.

What is Viemed Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 19 2024, VMD's PE ratio (Price to Earnings) is 25.67 and Price to Sales (PS) ratio is 1.37. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VMD PE ratio will change depending on the future growth rate expectations of investors.